Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3733)
All Articles published online
|
Nov 28, 2005 (publication date) through Feb 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kruis W, Dignass A, Steinhagen-Thiessen E, Morgenstern J, Mössner J, Schreiber S, Vecchi M, Malesci A, Reinshagen M, Löfberg R. Open label trial of granulocyte apheresis suggests therapeutic efficacy in chronically active steroid refractory ulcerative colitis. World J Gastroenterol 2005; 11(44): 7001-7006 [PMID: 16437606 DOI: 10.3748/wjg.v11.i44.7001] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i44/7001.htm |
| Number | Citing Articles |
| 1 |
J. Panés, M. Guilera, D. Ginard, J. Hinojosa, P. González-Carro, V. González-Lara, V. Varea, E. Domènech, X. Badia. Treatment cost of ulcerative colitis. Digestive and Liver Disease 2007; 39(7): 617 doi: 10.1016/j.dld.2007.03.007
|
| 2 |
Giampaolo Bresci, Giuseppe Parisi, Alessandro Mazzoni, Fabrizio Scatena, Alfonso Capria. Granulocytapheresis versus methylprednisolone in patients with acute ulcerative colitis: 12‐month follow up. Journal of Gastroenterology and Hepatology 2008; 23(11): 1678 doi: 10.1111/j.1440-1746.2008.05595.x
|
| 3 |
Abbi R. Saniabadi, Tomotaka Tanaka, Takayuki Yamamoto, Wolfgang Kruis, Rodolfo Sacco. Granulomonocytapheresis as a cell‐dependent treatment option for patients with inflammatory bowel disease: Concepts and clinical features for better therapeutic outcomes. Journal of Clinical Apheresis 2019; 34(1): 51 doi: 10.1002/jca.21670
|
| 4 |
Bruce E. Sands, William J. Sandborn, Brian Feagan, Robert Löfberg, Toshifumi Hibi, Tao Wang, Lisa–Marie Gustofson, Cindy J. Wong, Margaret K. Vandervoort, Stephen Hanauer. A Randomized, Double-Blind, Sham-Controlled Study of Granulocyte/Monocyte Apheresis for Active Ulcerative Colitis. Gastroenterology 2008; 135(2): 400 doi: 10.1053/j.gastro.2008.04.023
|
| 5 |
Reikei Matsuda, Tomoko Koide, Chikako Tokoro, Tsuyoshi Yamamoto, Tenʼi Godai, Taiki Morohashi, Yuji Fujita, Daisuke Takahashi, Ichiro Kawana, Shinichiro Suzuki, Satoshi Umemura. Quantitive Cytokine mRNA Expression Profiles in the Colonic Mucosa of Patients with Steroid Naïve Ulcerative Colitis During Active and Quiescent Disease. Inflammatory Bowel Diseases 2009; 15(3): 328 doi: 10.1002/ibd.20759
|
| 6 |
Giampaolo Bresci. Granulocytapheresis in the treatment of patients with active ulcerative colitis. Expert Review of Gastroenterology & Hepatology 2008; 2(5): 639 doi: 10.1586/17474124.2.5.639
|
| 7 |
Nobuhiro Ueno, Yuya Sugiyama, Yu Kobayashi, Yuki Murakami, Takuya Iwama, Takahiro Sasaki, Takehito Kunogi, Keitaro Takahashi, Kazuyuki Tanaka, Katsuyoshi Ando, Shin Kashima, Yuhei Inaba, Kentaro Moriichi, Hiroki Tanabe, Masaki Taruishi, Yusuke Saitoh, Toshikatsu Okumura, Mikihiro Fujiya. Fecal calprotectin is a useful biomarker for predicting the clinical outcome of granulocyte and monocyte adsorptive apheresis in ulcerative colitis patients: a prospective observation study. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01889-0
|
| 8 |
Luca Pastorelli, Theresa T Pizarro, Fabio Cominelli, Maurizio Vecchi. Emerging drugs for the treatment of ulcerative colitis. Expert Opinion on Emerging Drugs 2009; 14(3): 505 doi: 10.1517/14728210903146882
|
| 9 |
Shin-ichiro Takeda, Toru Sato, Tatsuro Katsuno, Tomoo Nakagawa, Yoshiko Noguchi, Osamu Yokosuka, Yasushi Saito. Adsorptive Depletion of α4 Integrinhi- and CX3CR1hi-Expressing Proinflammatory Monocytes in Patients with Ulcerative Colitis. Digestive Diseases and Sciences 2010; 55(7): 1886 doi: 10.1007/s10620-009-0974-2
|
| 10 |
Hiroyuki Hanai. Positions of selective leukocytapheresis in the medical therapy of ulcerative colitis. World Journal of Gastroenterology 2006; 12(47): 7568-7577 doi: 10.3748/wjg.v12.i47.7568
|
| 11 |
Iago Rodríguez‐Lago, José M. Benítez, Laura Sempere, Esteban Sáez‐González, Manuel Barreiro‐de Acosta, Jone O. de Zárate, José L. Cabriada. The combination of granulocyte‐monocyte apheresis and vedolizumab: A new treatment option for ulcerative colitis?. Journal of Clinical Apheresis 2019; 34(6): 680 doi: 10.1002/jca.21746
|
| 12 |
Lena Oxelmark, Pernilla Hillerås, Axel Dignass, Joachim Mössner, Stefan Schreiber, Wolfgang Kruis, Robert Löfberg. Quality of life in patients with active ulcerative colitis treated with selective leukocyte apheresis. Scandinavian Journal of Gastroenterology 2007; 42(3): 406 doi: 10.1080/00365520600881060
|
| 13 |
G. Bresci, G. Parisi, A. Mazzoni, F. Scatena, A. Capria. Treatment of patients with acute ulcerative colitis: Conventional corticosteroid therapy (MP) versus granulocytapheresis (GMA): A pilot study. Digestive and Liver Disease 2007; 39(5): 430 doi: 10.1016/j.dld.2007.01.001
|
| 14 |
Axel Dignass, James O. Lindsay, Andreas Sturm, Alastair Windsor, Jean-Frederic Colombel, Mathieu Allez, Gert D'Haens, André D'Hoore, Gerassimos Mantzaris, Gottfried Novacek, Tom Öresland, Walter Reinisch, Miquel Sans, Eduard Stange, Severine Vermeire, Simon Travis, Gert Van Assche. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management. Journal of Crohn's and Colitis 2012; 6(10): 991 doi: 10.1016/j.crohns.2012.09.002
|
| 15 |
Tomotaka Tanaka, Takayuki Yamamoto, Koji Sawada, Rodolfo Sacco. Treatment options for children and adolescents with inflammatory bowel disease: is granulomonocytapheresis an effective alternative to drug therapy?. Expert Review of Gastroenterology & Hepatology 2017; 11(8): 749 doi: 10.1080/17474124.2017.1341309
|
| 16 |
Granulocyte-Monocyte Apheresis in Steroid-Dependent, Azathioprine-Intolerant/Resistant Moderate Ulcerative Colitis: A Prospective Multicenter Study. Gastroenterology Research and Practice 2017; 2017: 1 doi: 10.1155/2017/9728324
|
| 17 |
Fridrik Thor Sigurbjörnsson, Ingvar Bjarnason. Leukocytapheresis for the treatment of IBD. Nature Clinical Practice Gastroenterology & Hepatology 2008; 5(9): 509 doi: 10.1038/ncpgasthep1209
|
| 18 |
Abbi R Saniabadi, Tomotaka Tanaka, Toshihide Ohmori, Koji Sawada, Takayuki Yamamoto, Hiroyuki Hanai. Treating inflammatory bowel disease by adsorptive leucocytapheresis: A desire to treat without drugs. World Journal of Gastroenterology 2014; 20(29): 9699-9715 doi: 10.3748/wjg.v20.i29.9699
|
| 19 |
Daniel Vasile Balaban, Mariana Jinga. Crohn’s Disease Recent Advances. 2021; doi: 10.5772/intechopen.93605
|
| 20 |
G. D’Haens. Emerging Issues in Inflammatory Bowel Diseases. Falk Symposium 2007; 151: 174 doi: 10.1007/978-1-4020-5702-1_19
|
| 21 |
Michael Friedt, Christian P. Braegger. Pädiatrische Gastroenterologie, Hepatologie und Ernährung. 2013; : 333 doi: 10.1007/978-3-642-24710-1_11
|
| 22 |
Melanie K Greifer, James F Markowitz. Update in the treatment of paediatric ulcerative colitis. Expert Opinion on Pharmacotherapy 2006; 7(14): 1907 doi: 10.1517/14656566.7.14.1907
|
| 23 |
Javier Martín-Carpi, Vicente Varea. Clinical, endoscopic and histological remission in paediatric chronically active ulcerative colitis after prolonged treatment with selective granulocyte–monocyte adsorptive apheresis. Journal of Crohn's and Colitis 2009; 3(3): 216 doi: 10.1016/j.crohns.2009.03.003
|
| 24 |
Dan Turner, Frank M. Ruemmele, Esther Orlanski‐Meyer, Anne M. Griffiths, Javier Martin de Carpi, Jiri Bronsky, Gabor Veres, Marina Aloi, Caterina Strisciuglio, Christian P. Braegger, Amit Assa, Claudio Romano, Séamus Hussey, Michael Stanton, Mikko Pakarinen, Lissy de Ridder, Konstantinos Katsanos, Nick Croft, Victor Navas‐López, David C. Wilson, Sally Lawrence, Richard K. Russell. Management of Paediatric Ulcerative Colitis, Part 1. Journal of Pediatric Gastroenterology and Nutrition 2018; 67(2): 257 doi: 10.1097/MPG.0000000000002035
|
| 25 |
Caroline Schultheiß, René Weischenberg, Andrea Herrmann, Bernhard Haller, Roland M. Schmid, Wolfgang Reindl, Wolfgang Huber. Dose‐Intensified Granulocyte‐Monocyte Apheresis in Therapy Refractory Ulcerative Colitis. Artificial Organs 2015; 39(2): 187 doi: 10.1111/aor.12329
|
| 26 |
Nobuhiro Ueno, Yuya Sugiyama, Yu Kobayashi, Yuki Murakami, Takuya Iwama, Takahiro Sasaki, Takehito Kunogi, Aki Sakatani, Keitaro Takahashi, Kazuyuki Tanaka, Shinya Serikawa, Katsuyoshi Ando, Shin Kashima, Momotaro Muto, Yuhei Inaba, Kentaro Moriichi, Hiroki Tanabe, Toshikatsu Okumura, Mikihiro Fujiya. Concomitant pharmacologic medications influence the clinical outcomes of granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis: A multicenter retrospective cohort study. Journal of Clinical Apheresis 2023; 38(4): 406 doi: 10.1002/jca.22040
|
| 27 |
Tomotaka Tanaka. Therapeutic Granulomonocytapheresis as a Non-pharmacologic Treatment Option for Inflammatory Bowel Disease: Efficacy Reports on a Wide Age Range and Disease Profile. Cureus 2023; doi: 10.7759/cureus.48913
|
| 28 |
José Luis Cabriada-Nuño, Antonio Bernal-Martínez, Anaiansi Hernández-Martín, Juan Antonio Arévalo-Serna, Encarnación Fernández-Prado. Aféresis leucocitaria en la inducción de la remisión y retirada de corticoides en la colitis ulcerosa corticodependiente. Diálisis y Trasplante 2007; 28(2): 47 doi: 10.1016/S1886-2845(07)71352-8
|
| 29 |
Sunana Sohi, Russell D. Cohen. Management of refractory ulcerative colitis. Current Treatment Options in Gastroenterology 2006; 9(3): 234 doi: 10.1007/s11938-006-0042-3
|
| 30 |
S. Ihara, Y. Yamaji, H. Kinoshita, A. Yamada, Y. Hirata, K. Hasegawa, Y. Sugawara, N. Kokudo, K. Koike. First Case Report of De Novo Ulcerative Colitis Developing After Orthotopic Liver Transplantation Successfully Treated by Granulocyte and Monocyte Apheresis. Transplantation Proceedings 2014; 46(7): 2414 doi: 10.1016/j.transproceed.2014.02.016
|
| 31 |
Takafumi Ando, Yuji Nishio, Osamu Watanabe, Hironao Takahashi, Osamu Maeda, Kazuhiro Ishiguro, Daisuke Ishikawa, Naoki Ohmiya, Yasumasa Niwa, Hidemi Goto. Value of colonoscopy for prediction of prognosis in patients with ulcerative colitis. World Journal of Gastroenterology 2008; 14(14): 2133-2138 doi: 10.3748/wjg.14.2133
|
| 32 |
J. L. Cabriada, E. Domènech, N. Ibargoyen, V. Hernández, J. Clofent, D. Ginard, I. Gutiérrez-Ibarluzea, J. Hinojosa. Leukocytapheresis for steroid-dependent ulcerative colitis in clinical practice: results of a nationwide Spanish registry. Journal of Gastroenterology 2012; 47(4): 359 doi: 10.1007/s00535-011-0499-2
|
| 33 |
Abbi R. Saniabadi, Hiroyuki Hanai, Ken Fukunaga, Koji Sawada, Chikako Shima, Ingvar Bjarnason, Robert Lofberg. Therapeutic leukocytapheresis for inflammatory bowel disease. Transfusion and Apheresis Science 2007; 37(2): 191 doi: 10.1016/j.transci.2007.08.003
|
| 34 |
Axel Dignass, Ayesha Akbar, Daniel C. Baumgart, Gilles Bommelaer, Guillaume Bouguen, Guillaume Cadiot, Anton Gillessen, Jean-Charles Grimaud, Ailsa Hart, Syed Hoque, Richard Makins, Christophe Michiels, Jacques Moreau, Purushothaman Premchand, Wolfgang Ramlow, Stefan Schanz, Sreedhar Subramanian, Christian von Tirpitz, Bruno Bonaz. Granulocyte/monocyte adsorptive apheresis for the treatment of therapy-refractory chronic active ulcerative colitis. Scandinavian Journal of Gastroenterology 2018; 53(4): 442 doi: 10.1080/00365521.2018.1447598
|
| 35 |
Masahiro Sakai, Koichi Hayashi, Tomoyuki Ito, Haruka Otani, Yuya Mori, Shinsuke Ito, Keita Endo, Hiroto Matsuda, Kaede Yoshino, Koichi Kitamura, Eiji Kubota, Yasuaki Motomura, Yasuhiro Suzuki, Shigeki Fujitani, Toshihiko Suzuki. Sustained effect of leukocytapheresis/granulocytapheresis versus anti-human TNF-α monoclonal antibody on ulcerative colitis: A 2-year retrospective study. Medicine 2023; 102(16): e33368 doi: 10.1097/MD.0000000000033368
|
| 36 |
Axel Dignass, Ayesha Akbar, Ailsa Hart, Sreedhar Subramanian, Gilles Bommelaer, Daniel C. Baumgart, Jean-Charles Grimaud, Guillaume Cadiot, Richard Makins, Syed Hoque, Guillaume Bouguen, Bruno Bonaz. Safety and Efficacy of Granulocyte/Monocyte Apheresis in Steroid-Dependent Active Ulcerative Colitis with Insufficient Response or Intolerance to Immunosuppressants and/or Biologics [the ART Trial]: 12-week Interim Results. Journal of Crohn's and Colitis 2016; 10(7): 812 doi: 10.1093/ecco-jcc/jjw032
|
| 37 |
José Luis Cabriada. Aféresis en enfermedad inflamatoria intestinal. ¿Una opción válida?. Gastroenterología y Hepatología 2012; 35(1): 22 doi: 10.1016/j.gastrohep.2011.10.005
|
| 38 |
Pilar Nos, Eugeni Domènech. Tratamiento con aféresis en la enfermedad inflamatoria intestinal. Gastroenterología y Hepatología 2009; 32(7): 509 doi: 10.1016/j.gastrohep.2009.01.183
|
| 39 |
Hiroaki Takeda, Yasukuni Suzuki, Yuji Takeda, Shoichi Nishise, Tadahisa Fukui, Shoichiro Fujishima, Tomohiko Orii, Sayaka Otake, Takeshi Sato, Koji Suzuki, Yukiko Nakamuara, Sumio Kawata. A multi center study of granulocyte and monocyte adsorption apheresis therapy for ulcerative colitis—Clinical efficacy and production of interleukin‐1 receptor antagonist. Journal of Clinical Apheresis 2008; 23(3): 105 doi: 10.1002/jca.20164
|
| 40 |
David Schwartz, John R. Ferguson. Current pharmacologic treatment paradigms for inflammatory bowel disease and the potential role of granulocyte/monocyte apheresis. Current Medical Research and Opinion 2007; 23(11): 2715 doi: 10.1185/030079907X233241
|
| 41 |
A. Dignass, J.O. Lindsay, A. Sturm, A. Windsor, J.-F. Colombel, M. Allez, G. d’Haens, A. d’Hoore, G. Mantzanaris, G. Novacek, T. Öresland, W. Reinisch, M. Sans, E. Stange, S. Vermeire, S. Travis, G. van Assche. Segundo consenso europeo basado en evidencia sobre el diagnóstico y manejo de la colitis ulcerosa crónica idiopática. Parte 2: tratamiento actual (versión española). Revista de Gastroenterología de México 2015; 80(1): 32 doi: 10.1016/j.rgmx.2014.10.007
|
| 42 |
H. Hanai, T. Iida, K. Takeuchi, F. Watanabe, Y. Maruyama, M. Kageoka, K. Ikeya, M. Yamada, M. Kikuyama, Y. Iwaoka, K. Hirayama, S. Nagata, Y. Sato, Y. Hosoda. Intensive granulocyte and monocyte adsorption versus intravenous prednisolone in patients with severe ulcerative colitis: An unblinded randomised multi-centre controlled study. Digestive and Liver Disease 2008; 40(6): 433 doi: 10.1016/j.dld.2008.01.007
|
| 43 |
A. U. DIGNASS, A. ERIKSSON, A. KILANDER, A. PUKITIS, J. M. RHODES, S. VAVRICKA. Clinical trial: five or ten cycles of granulocyte–monocyte apheresis show equivalent efficacy and safety in ulcerative colitis. Alimentary Pharmacology & Therapeutics 2010; 31(12): 1286 doi: 10.1111/j.1365-2036.2010.04295.x
|